Stress management and psychoneuroimmunology in HIV infection

CNS Spectrums

Volumn 8, Issue 1, 2003, Pages 40-51

  Antoni, Michael H ^a,b  

^a UNIVERSITY OF MIAMI   (United States)

^b Department of Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFECT; ANXIETY DISORDER; BEHAVIOR; BISEXUALITY; COGNITION; COGNITIVE THERAPY; COPING BEHAVIOR; CYTOTOXICITY; DEPRESSION; DISEASE COURSE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; IMAGERY; IMMUNOSURVEILLANCE; LATENT VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MALIGNANT NEOPLASTIC DISEASE; NEUROENDOCRINOLOGY; OPPORTUNISTIC INFECTION; PATIENT ATTITUDE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOPHYSIOLOGY; RELAXATION TRAINING; REVIEW; SELF CONCEPT; SKILL; SOCIAL ASPECT; SOCIAL ISOLATION; STRESS; SYMPTOMATOLOGY; TRAINING; VIRUS LOAD; VIRUS REPLICATION; ADAPTIVE BEHAVIOR; AROUSAL; IMMUNOCOMPETENCE; IMMUNOLOGY; LIFE EVENT; PHYSIOLOGY; SOCIAL ADAPTATION;

ADAPTATION, PSYCHOLOGICAL; AROUSAL; HIV INFECTIONS; HUMANS; IMMUNOCOMPETENCE; LIFE CHANGE EVENTS; PSYCHONEUROIMMUNOLOGY; SOCIAL ADJUSTMENT;

EID: 0037261062     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900023440     Document Type: Review

References (83)

1. Pantaleo G, Graziosi C, Fauei AS. The immunopathogenesis of human immunodeficiency virus infection. N Eng J Med. 1993;328:327-335.
2. Kaplan LD, Wofsky CB, Volberding PA. Treatment of patients with acquired immunodeficiency syndrome and associated manifestations. JAMA. 1987;257:1367-1376.
3. Maiman M, Fruchter R. Cervical neoplasia and the human immunodeficiency virus. In: Rubino S, Hoskins W, eds. Cervical Cancer and Preinvasive Neoplasia. Philadelphia, Pa: Lippincott-Raven; 1996:405-416.
4. Zur Hausen H. Papillomaviruses and cancer: from basic studis to clinical application. Nat Rev Cancer. 2002;2:342-350.
5. Ironson G, Friedman A, Klimas N, et al. Distress, denial and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus. Int J Behav Med. 1994;1:90-105.
6. Antoni MH, Schneiderman N, Fletcher MA, et al. Psychoneuroimmunology and HIV-1. J Consult Clin Psychol. 1990;58:38-49.
7. Schneiderman N, Antoni MH, Saab P, Ironson G. Health psychology: psychosocial and biobehavioral aspects of chronic disease management. Annu Rev Psychol 2001;52:555-580.
8. Antoni MH, Schneiderman N. HIV/AIDS In: Bellack A, Hersen M, eds. Comprehensive Clinical Psychology. New York, NY: Elsevier Science; 1998:237-275.
9. Klimas N, Caralis P, LaPerriere A, et al. Evaluation of immunological status in a cohort of HIV-1 positive and negative healthy gay men. J Clin Microbiol. 1991;29:1413-1421.
10. Ironson G, Balbin E, Solomon G, et al. Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts. AIDS. 2001;15:2065-2073.
11. Antoni MH, Esterling B, Lutgendorf S, Fletcher MA, Schneiderman N. Psychosocial stressors, herpesvirus reactivation and HIV-1 infection. In: Stein M, Baum A, eds. AIDS and Oncology: Perspectives in Behavioral Medicine. Hillsdale, NJ: Erlbaum; 1995:135-168.
12. Glaser R, Kiecolt-Glaser J. Stress-associated depression in cellular immunity: implications for acquired immune deficiency syndrome (AIDS). Brain Behav Immun. 1987;1:107-112.
13. Carbonari M, Fiorilli M, Mezzaroma I, Cherchi M, Aiuti F. CD4 as the receptor for retroviruses of the HTLV family: immunopathogenetic implications. Adv Exp Med Biol. 1989;257:3-7.
14. Rosenberg ZF, Fauci AS. Activation of latent HIV infection. J NIH Res. 1991;2:41-45.
15. Boshoff C, Weiss R. AIDS-related malignancies. Nat Rev Cancer. 2002;2:373-382.
16. Byrnes D, Antoni MH, Goodkin K, et al. Stressful events, pessimism, natural killer cell cytotoxicity and cytotoxic/suppressor T cells in HIV+ Black women at risk for cervical cancer. Psychosom Med. 1998;60:714-722.
17. Pereira D, Antoni MH, Simon T, et al. Stress and squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom Med. In press.
18. Griffiths PD, Grundy JE. Molecular biology and immunology of cytomegalovirus. J Biochem (Tokyo). 1987;241:313-324.
19. McEwen B. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171-179.
20. Calabrese J, King M, Gold P. Alterations in immunocompetence during stress, bereavement, and depression: focus on neuroendocrine regulation. Am J Psychiatry. 1987;144:1123-1134.
21. Kiecolt-Glaser J, Ricker D, George J, et al. Urinary cortisol levels, cellular immunocompetency, and loneliness in psychiatric inpatients. Psychosom Med. 1984;46:15-23.
22. Markham P, Salahuddin S, Veren K, Orndorff S, Gallo R. Hydrocortisone and some other hormones enhance the expression of HTLV-III. Int J Cancer. 1986;37:67-72.
23. Clerici M, Trabattoni D, Piconi S, et al. A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus. Psychoneuroendocrinology. 1997;22(suppl 1):S27-S31.
24. Lortholary O, Christeff N, Casassus P et al. Hypothalamic-pituitary-adrenal function in human immunodeficiency virus-infected men. J Clin Endocrin Metabol. 1996;81:791-796.
25. Kumar M, Kumar A, Morgan R, Szapocznik J, Eisdorfer C. Abnormal pituitary-adrenocortical response in early HIV-1 infection. J Acquir Immune Defic Syndr. 1993;6:61-65.
26. Rondanelli M, Solerte S, Fioravanti M, et al. Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection. AIDS Res Hum Retroviruses. 1997;13:1243-1249.
27. Plaut M. Lymphocyte hormone receptors. Annu Rev Immunol. 1987;5:621-669.
28. Manuck S, Cohen S, Rabin B. Individual differences in cellular immune responses to stress. Psychol Sci. 1991:2:111-115.
29. Cole S, Korin Y, Fahey J, Zack J. Norepinephrine accelerates HIV replication via protein kinase-A dependent effects on cytokine production. J Immunol. 1998;161:610-616.
30. Webster E, Elenkov I, Chrousos G. The role of corticotropin-releasing hormone in neuroendocrine-immune interactions. Mol Psychiatry. 1997;2:368-372.
31. Cole S, Kemeny M. Psychosocial influences on the progression of HIV infection. In: Ader R, Cohen N, Felten D, eds. Psychoneuroimmunology. 3rd ed. New York, NY: Academic Press; 2001:583-612
32. Cole S, Kemeny M, Naliboff B, Fahey J, Zack J. ANS enhancement of HIV pathogenesis. Brain Behav Immun. 2001;15:121.
33. Maier SF, Watkins LR, Fleshner M. Psychoneuroimmunology: the interface between behavior, brain, and immunity. Am Psychol. 1994;49:1004-1017.
34. Ironson G, Antoni MH, Schneiderman N, et al. Coping: interventions for optimal disease management. In: Chesney M, Antoni MH, eds. Health Psychology Innovations: New Target Populations for Prevention and Care. Washington, DC: American Psychological Association; 2002:167-196.
35. Coates T, McKusick L, Stites D, Kuno R. Stress management training reduced number of sexual partners but did not improve immune function in men infected with HIV. Am J Public Health. 1989;79:885-887.
36. Auerbach JH, Oleson TD, Solomon GF. A behavioral medicine intervention as an adjunctive treatment for HIV-related illness. Psychol Health. 1992;6:325-334.
37. Simons A, Garfield S, Murphy G. The process of change in cognitive therapy and pharmacotherapy: changes in mood and cognition. Arch Gen Psychiatry. 1984;41:45-51.
38. Folkman S, Chesney M, McKusick L, et al. Translating coping theory into intervention. In: J. Eckenrode, ed. The Social Context of Stress. New York, NY: Plenum; 1991;239-260.
39. Antoni MH. Cognitive behavioral stress management for gay men learning of their HIV-1 antibody test results. In: Spira J, ed. Group Therapy for Patients With Chronic Medical Diseases. New York, NY: Guilford Press; 1997:55-91.
40. Antoni MH, Ironson G, Lutgendorf S. Psychosocial intervention in HIV infection. In: Nott K, Vedhara K, eds. Psychosocial And Biomedical Interaction in HIV Infection. Amsterdam, Netherlands: Hanvood Academic Publishers; 2000;253-296.
41. Antoni MH, Baggett L, Ironson G, et al. Cognitive behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. J Consult Clin Psychol. 1991;59:906-915.
42. Esterling B, Antoni M, Schneiderman N, et al. Psychosocial modulation of antibody to Epstein-Barr viral capsid antigen and herpes virus type-6 in HIV-1 infected and at-risk gay men. Psychosom Med. 1992;54:354-371.
43. Antoni MH, Lutgendorf S, Ironson G, Fletcher MA, Schneiderman N. CBSM intervention effects on social support, coping, depression and immune function in symptomatic HIV-infected men [abstract]. Psychosom Med. 1996;58:86.
44. LaPerriere A, Antoni MH, Schneiderman N, et al. Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1. Biofeedback Self Regul. 1990;15:125-131.
45. Cruess D, Antoni MH, Schneiderman N, et al. Cognitive behavioral stress management effects on DHEA-S and serum cortisol in HIV seropositive men. Psychoneuroendocrinology. 1999;24:537-549.
46. Cruess D, Antoni MH, Schneiderman N, et al. Cognitive behavioral stress management increases free testosterone and decreases psychological distress in HIV seropositive men. Health Psychol. 2000;19:12-20.
47. Cruess D, Antoni MH, Kumar M, Schneiderman N. Reductions in salivary cortisol are associated with mood improvement during relaxation training among HIV-1 seropositive men. J Behav Me. 2000;23:107-122.
48. Cruess S, Antoni MH, Cruess D, et al. Reductions in HSV-2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV+ gay men. Psychosom Med. 2000;62:828-837.
49. Antoni MH, Wagner S, Cruess D, et al. Cognitive behavioral stress management reduces distress and 24-hour urinary free cortisol among symptomatic HIV-infected gay men. Ann Behav Med. 2000;22:29-37.
50. Antoni MH, Cruess D, Wagner S, et al. Cognitive behavioral stress management effects on anxiety, 24-hour urinary catecholamine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. J Consult Clin Psychol. 2000;68:31-45.
51. Antoni MH, Cruess D, Klimas N, et al. Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: effects on transitional naïve T-cells (CD4+CD45RA+CD29+). Am J Psychiatry. 2002;159:143-145.
52. Kubler-Ross E. On Death and Dying. New York, NY: MacMillan; 1969.
53. Lechner S, Antoni MH, Lydston D, et al. Cognitive-behavioral interventions improve quality of life in women with AIDS. J Psychosom Res. In press.
54. Friedman A, Anoni MH, Ironson G, et al. Behavioral interventions, changes in perceived social support and depression following notification of HIV-1 seropositivity. Paper presented at: Annual Meeting of the Society of Behavioral Medicine; April, 1991; Washington, DC.
55. Lutgendorf S, Antoni MH, Schneiderman N, Ironson G, Fletcher MA. Psychosocial interventions and quality of life changes across the HIV spectrum. In: Baum A, Dimsdale J, eds. Perspectives in Behavioral Medicine. Lawrence Elbaum Associates, Inc.: Mahwah, NJ; 1994:205-239.
56. Kelly J, Murphy D, Bahr R, et al. Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. Am J Psychiatry. 1993;150:1679-1686.
57. Mulder CL, Emmelkamp P, Antoni MH, et al. Cognitive-behavioral and experiential group psychotherapy for HIV-infected homosexual men: a comparative study. Psychosom Med. 1994;56:423-431.
58. Chesney MA, Folkman S, Chambers D. Coping effectiveness training for men living with HIV: preliminary findings. Int J STD AIDS. 1996;7(suppl 2):75-82.
59. Goodkin K, Tuttle R, Blaney NT, et al. A bereavement support group intervention is associated with immunological changes in HIV-1+ and HIV-1-homosexual men [abstract]. Psychosom Med. 1996;58:83-84.
60. Goodkin K, Feaster D, Asthana D, et al. A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visits. Clin Diagn Lab Immunol. 1998;5:382-391.
61. Goodkin K, Baldewicz T, Asthana DP, et al. A bereavement support group intervention affects plasma burden of HIV-1. J Hum Virol. 2001;4:44-54.
62. Lutgendorf S, Antoni M, Ironson G, et al. Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men. Psychosom Med. 1998;60:204-214.
63. Cruess S, Antoni MH, Hayes A, et al. Changes in mood and depressive symptoms and related change processes during cognitive behavioral stress management in HIV-infected men. Cognit Ther Res. 2002;26:373-392.
64. Antoni MH, Lehman J, Kilbourn K, et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 2001;20:20-32.
65. Yang JY, Schwartz A, Henderson EE. Inhibition of 3′ azido-3′ deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro. Biochem Biophys Res Commun. 1994;201:1424-1432.
66. Yang JY, Schwartz A, Henderson EE. Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA. AIDS Res Hum Retroviruses. 1993;9:747-754.
67. Ironson G, Antoni M Lutgendorf S. Can psychological interventions affect immunity and survival? Present findings and suggested targets with a focus on cancer and human immunodeficiency virus. Adv Mind Body Med. 1995;1:85-110.
68. Ironson G, Field T, Scafidi F, et al. Massage therapy is associated with enhancement of the immune systems cytotoxic capacity. Int J Neurosci. 1996;84:205-217.
69. Madden K, Sanders V, Felten D. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol. 1995;35:417-448.
70. Mills P, Ziegler M, Patterson T, et al. Plasma catecholamine and lymphocyte beta 2-adrenergic receptor alterations in elderly Alzheimer caregivers under stress. Psychosom Med. 1997;59:251-256.
71. Landmann R. Beta-adrenergic receptors in human leukocyte subpopulations. European Journal of Clinical Investigations [abstract]. 1992;22(suppl 1):30.
72. Felten, D. Changes in the neural innervation of lymphoid tissues with age. In: Hall N, Altman F, Blumenthal S, eds. Mind-Body Interactions and Disease and Psychoneuroimmunological Aspects of Health and Disease. Washington, DC: Health Dateline Press; 1996:157-164.
73. Maher K, Klimas N, Dickinson G, et al. T lymphocyte subsets and Highly Active Antiretroviral Therapy (HAART) of HIV infection. Applications in Clinical Cytometry. In press.
74. Musey L, Hughes J, Schacker T. Cytotoxic T-cell responses, viral load and disease progression in early human immunodeficiency virus type I infection. N Engl J Med. 1997;337:1267-1274.
75. Picker L, Treer J, Ferguson-Darnell B, et al. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-Selectin on T cells during the virgin to memory cell transition. J Immunol. 1993;150:1105-1121.
76. Connors M, Kovacs J, Krevat S, et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med. 1997;3:533-540.
77. West-Edwards C, Pereira D, Greenwood D, et al. An investigation of the psychological and immune effects of a cognitive behavioral stress management (CBSM) intervention for HIV+ African American women [abstract]. Ann Behav Med. 2001;23:12.
78. Markowitz JC, Kocsis JH, Fishman B, et al. Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Arch Gen Psychiatry. 1998;55:452-457
79. Ekstrand M, Chesney M. Adhering to complex medication regimens. In: Chesney M, Antoni MH, eds. Health Psychology Innovation: New Target Populations for Prevention and Care. Washington, DC: American Psychological Association; 2002:283-306
80. Schneiderman N, Antoni MH, Ironson G. Cognitive behavioral stress management and secondary prevention in HIV/AIDS. Psychology and AIDS Exchange. 1997;22:1-8.
81. Motivala S, Hurwitz B, Antoni MH, et al. Psychological distress is associated with decreased memory T-cells and B-cells in pre-AIDS HIV seropositive men and women. Psychosom Med. In press.
82. Spiegel D, Bloom GC, Kraemer JS, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989;2:888-891.
83. Goodwin P, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001;345:1719-1726.